

Ep. 285: “Funding the Future” Featuring Dr. Jonathan Thomas
Jan 7, 2025
Dr. Jonathan Thomas, President and CEO of the California Institute for Regenerative Medicine (CIRM), shares his insights on funding vital stem cell research. He discusses the importance of diversity in clinical trials to make treatments accessible. JT reflects on CIRM's 20-year journey in advancing research and training future scientists. The conversation also dives into balancing support between basic and clinical research, along with CIRM's strategic shift post-Proposition 14 to navigate the evolving landscape of regenerative medicine.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 2min
Unlocking Naive Pluripotency
02:24 • 9min
Insights into Skin Wound Healing
11:35 • 8min
Navigating Stem Cell Regeneration and Niche Dynamics
19:37 • 20min
Innovations in Stem Cell Research and Leadership Changes
39:13 • 3min
Navigating Changes at CIRM
42:31 • 10min
CIRM: Pioneering Stem Cell Research and Education
52:14 • 25min
Navigating Stem Cell Hope and Hype
01:17:08 • 14min